title: Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
abstract: Tick-borne encephalitis (TBE) circulates widely in the territory of Eurasia with up to 10,000 cases registered annually. The TBE virus (TBEV) includes three main subtypes: European, Siberian and Far-Eastern, and two new Asiatic variants, phylogenetically distant from the others. The inactivated antigen of European or Far-Eastern strains is used in commercial TBE vaccines. A set of 14 TBEV strains, isolated in 1937-2008, with different passage histories, representing all subtypes and variants, was used in this work. The chosen set covers almost all the TBE area. Sera of mice, immunized with the TBE vaccine Moscow, prepared from the TBEV strain Sofjin, were studied in a plaque neutralization test against the set of TBEV strains. The vaccine induced antibodies at a protective titer against all TBEV strains and Omsk hemorrhagic fever virus (OHFV) with Е protein amino acid distances of 0.008-0.069, but not against Powassan virus. We showed that after a course of two immunizations, factors such as the period between vaccinations (1-4 weeks), the challenging virus dose (30-1000 LD50) and terms of challenge (1-4 weeks after the last immunization) did not significantly affect the assessment of protective efficacy of the vaccine in vivo. The protective effect of the TBE vaccine Moscow against the set of TBEV strains and the OHFV was demonstrated in in vivo experiments. TBE vaccine Moscow did not protect mice against 10 LD50 of the Powassan virus. We showed that this range of Е protein amino acid distances between the vaccine strain and challenging virus do not have a decisive impact on the TBE vaccine protective effect in vitro and in vivo. Moreover, the TBE vaccine Moscow induces an immune response protective against a wide range of TBEV variants.
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: L L
authors.initials: LL
authors.lastname: Chernokhaeva
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: Yu V
authors.initials: YV
authors.lastname: Rogova
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: M F
authors.initials: MF
authors.lastname: Vorovitch
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: L Iu
authors.initials: LIu
authors.lastname: Romanova
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: L I
authors.initials: LI
authors.lastname: Kozlovskaya
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: G B
authors.initials: GB
authors.lastname: Maikova
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia.
authors.forename: I S
authors.initials: IS
authors.lastname: Kholodilov
authors.affiliation: Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782 Russia. Electronic address: karganova@bk.ru.
authors.forename: G G
authors.initials: GG
authors.lastname: Karganova
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D056738:Cross Protection; D004669:Encephalitis Viruses, Tick-Borne / Q000145:classification; D004675:Encephalitis, Tick-Borne / Q000517:prevention & control*; D051379:Mice; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests; D010802:Phylogeny; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C065696:glycoprotein E, Flavivirus
keywords: Antibody; Flavivirus; OHFV; Powassan virus; TBE vaccine; TBEV